Found 32 matching trials
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer
PHASE1This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Location
Peking University Shenzhen Hospital
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
N/AThis is a non-interventional observational study aiming to evaluate the qua...
Location
Seoul St. Mary Hospital
Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)
PHASE1This study tests the safety and preliminary anti-tumor activity of an inves...
Location
Peking University Shenzhen Hospital
Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer
PHASE1This example Phase 1 study is designed to evaluate the safety, tolerability...
Location
Peking University Shenzhen Hospital
Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer
PHASE1This example planning study proposes a phase 1/2 evaluation of an allogenei...
Location
Peking University Shenzhen Hospital
Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer
PHASE1This Phase 1/2 study evaluates the safety, tolerability, and preliminary an...
Location
Peking University Shenzhen Hospital
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
PHASE1This hypothetical first-in-human study is designed to evaluate the safety, ...
Location
Peking University Shenzhen Hospital
Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma
PHASE1This example study evaluates the safety, tolerability, and preliminary anti...
Location
Peking University Shenzhen Hospital
Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
PHASE1This example study is an open-label, multi-center, adaptive Phase 1/2 trial...
Location
Peking University Shenzhen Hospital
Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC
PHASE1This study tests the safety and preliminary anti-tumor activity of an inves...
Location
Peking University Shenzhen Hospital